Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Growth stocks with moderate risk

Article Abstract:

A list of 16 stocks with low-to-moderate risk and worthwhile long-term appreciation potential is presented. Included in the list are the shares of Amgen, Autoliv, Inc., ChoicePoint Inc., Danaher Corp., and Disney. The ratings for the stocks' timeliness and safety, and the companies' financial strength are also supplied.

Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2008

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Growth stocks with moderate risk

Article Abstract:

A list of 14 stocks with low-to-moderate risk and worthwhile long-term appreciation potential is presented. Included in the list are the shares of Amer. Greetings, Amgen, Brown & Brown and Can. National Railway. The stocks' financial strength and timeliness ratings are also given.

Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2008

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Evaluation, Stocks, Stock prices, Table
Similar abstracts:
  • Abstracts: Growth stocks with moderate risk. Growth stocks with moderate risks
  • Abstracts: Timely stocks with high return on equity. Timely stocks with low risk
  • Abstracts: Timely stocks with high return on equity. Advantages and disadvantages of E/C international standards
  • Abstracts: Economic and stock market commentary. The quarterly economic review
  • Abstracts: On assuring valid measures for theoretical models using survey data. AOL Time Warner, Terra Lycos, Vivendi, and the transformation of marketing
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.